Most of the pharmacogenetic Parkinson’s can be recovered, but not always completely normalized.
Pharmacogenetic Parkinson’s syndrome is one of the most common medically induced disorders, a syndrome in which tremor, increased muscle tone, and decreased movement are the main clinical manifestations associated with medication, and which also severely affects the lives and quality of life of patients taking medication.
The prognosis of pharmacogenetic Parkinson’s is related to whether or not the drug causing Parkinson’s is discontinued, the duration of drug discontinuation, the duration of onset of the disease, and whether or not it causes serious functional impairment.
Since patients with pharmacogenetic Parkinson’s are not primary Parkinson’s, their condition will gradually improve after stopping the medication causing Parkinson’s symptoms, and a few patients will have some residual Parkinson’s-induced dysfunction, such as muscle tone enhancement, motor dysfunction, and so on.
Rehabilitation methods such as exercise therapy, occupational therapy, and physical factor therapy can be used for functional recovery. These dysfunctions can still be further improved by further rehabilitation.
After the occurrence of pharmacogenetic Parkinson’s, it is recommended to seek medical treatment in time and formulate a treatment plan after clarifying the cause of the disease for a good prognosis.